Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review

Joint Authors

Faiella, Whitney
Atoui, Rony

Source

Stem Cells International

Issue

Vol. 2016, Issue 2016 (31 Dec. 2015), pp.1-7, 7 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2015-12-29

Country of Publication

Egypt

No. of Pages

7

Abstract EN

Stem cell transplantation is a potential therapeutic option to regenerate damaged myocardium and restore function after infarct.

Current research is focused on the use of allogeneic mesenchymal stem cells (MSCs) due to their unique immunomodulatory characteristics and ability to be harvested from young and healthy donors.

Both animal and human studies support the immunoprivileged state of MSCs and even demonstrate improvements in cardiac function after transplantation.

This research continues to be a topic of interest, as advances will ultimately enable the clinical use of these universal cells for therapy after a myocardial infarction.

Updated in vitro, in vivo, and clinical trial studies are discussed in detail in the following review.

American Psychological Association (APA)

Faiella, Whitney& Atoui, Rony. 2015. Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review. Stem Cells International،Vol. 2016, no. 2016, pp.1-7.
https://search.emarefa.net/detail/BIM-1116147

Modern Language Association (MLA)

Faiella, Whitney& Atoui, Rony. Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review. Stem Cells International Vol. 2016, no. 2016 (2015), pp.1-7.
https://search.emarefa.net/detail/BIM-1116147

American Medical Association (AMA)

Faiella, Whitney& Atoui, Rony. Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review. Stem Cells International. 2015. Vol. 2016, no. 2016, pp.1-7.
https://search.emarefa.net/detail/BIM-1116147

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1116147